NASDAQ: NEWTNewtekone Inc Stock
$12.73-0.15 (-1.16%)
Updated Aug 11, 2026
NEWT Price
$12.73
Fair Value Price
N/A
Market Cap
$367.70M
52 Week Low
$9.59
52 Week High
$15.69
P/E
5.71x
P/B
0.89x
P/S
1.67x
PEG
0.79x
Dividend Yield
5.97%
Revenue
$256.48M
Earnings
$65.45M
Gross Margin
100%
Operating Margin
33.45%
Profit Margin
24.1%
Debt to Equity
6.71
Operating Cash Flow
-$739M
Beta
1.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NEWT Overview
NewtekOne, Inc. operates as a financial holding firm, specializing in delivering a comprehensive suite of business and financial solutions. Its diverse portfolio encompasses several key brands, including Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. Barry Sloane founded the company in 1998, and it maintains its corporate headquarters in Boca Raton, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NEWT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
NEWT
Ranked#258 of 287
Ranked#258 of 287
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $80.40 | A | |
| $25.59 | A | |
| $29.28 | B |
Be the first to know about important NEWT news, forecast changes, insider trades & much more!
NEWT News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NEWT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NEWT ($12.73) is trading below its intrinsic value of $16.30, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NEWT is good value based on its earnings relative to its share price (5.71x), compared to the US market average (12.31x)
P/E vs Market Valuation
NEWT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NEWT due diligence checks available for Premium users.
Valuation
NEWT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
5.71x
Industry
14.62x
Market
12.31x
NEWT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NEWT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NEWT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.89x
Industry
1.34x
NEWT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NEWT price to earnings growth (PEG)
For valuing profitable companies with growth potential
NEWT is good value based... subscribe to Premium to read more.
PEG Value Valuation
NEWT's financial health
Profit margin
Revenue
$63.0M
Net Income
$14.6M
Profit Margin
21.5%
NEWT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.2B
Liabilities
$2.8B
Debt to equity
6.71
NEWT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NEWT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$163.3M
Investing
-$139.8M
Financing
$295.1M
NEWT vs Bank Stocks
Newtekone Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.